These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 28785006
1. A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding. Yao G, Lam KH, Weisemann J, Peng L, Krez N, Perry K, Shoemaker CB, Dong M, Rummel A, Jin R. Sci Rep; 2017 Aug 07; 7(1):7438. PubMed ID: 28785006 [Abstract] [Full Text] [Related]
2. Characterization of a highly neutralizing single monoclonal antibody to botulinum neurotoxin type A. Brier S, Rasetti-Escargueil C, Wijkhuisen A, Simon S, Marechal M, Lemichez E, Popoff MR. FASEB J; 2021 May 07; 35(5):e21540. PubMed ID: 33817838 [Abstract] [Full Text] [Related]
3. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Fu Z, Chen C, Barbieri JT, Kim JJ, Baldwin MR. Biochemistry; 2009 Jun 23; 48(24):5631-41. PubMed ID: 19476346 [Abstract] [Full Text] [Related]
4. Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells. Lam KH, Perry K, Shoemaker CB, Jin R. Toxins (Basel); 2020 Sep 27; 12(10):. PubMed ID: 32992561 [Abstract] [Full Text] [Related]
5. Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A. Benoit RM, Frey D, Hilbert M, Kevenaar JT, Wieser MM, Stirnimann CU, McMillan D, Ceska T, Lebon F, Jaussi R, Steinmetz MO, Schertler GF, Hoogenraad CC, Capitani G, Kammerer RA. Nature; 2014 Jan 02; 505(7481):108-11. PubMed ID: 24240280 [Abstract] [Full Text] [Related]
6. N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A. Yao G, Zhang S, Mahrhold S, Lam KH, Stern D, Bagramyan K, Perry K, Kalkum M, Rummel A, Dong M, Jin R. Nat Struct Mol Biol; 2016 Jul 02; 23(7):656-62. PubMed ID: 27294781 [Abstract] [Full Text] [Related]
11. Structural insights into the interaction of botulinum neurotoxin a with its neuronal receptor SV2C. Li X, Brunner C, Wu Y, Leka O, Schneider G, Kammerer RA. Toxicon; 2020 Feb 02; 175():36-43. PubMed ID: 31783045 [Abstract] [Full Text] [Related]
13. Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography. Kumaran D, Adler M, Levit M, Krebs M, Sweeney R, Swaminathan S. Bioorg Med Chem; 2015 Nov 15; 23(22):7264-73. PubMed ID: 26522088 [Abstract] [Full Text] [Related]
19. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner. Strotmeier J, Lee K, Völker AK, Mahrhold S, Zong Y, Zeiser J, Zhou J, Pich A, Bigalke H, Binz T, Rummel A, Jin R. Biochem J; 2010 Oct 15; 431(2):207-16. PubMed ID: 20704566 [Abstract] [Full Text] [Related]